secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001641172-25-009262
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros Q1 2025 revenue $4.9M (+38% YoY), net income $558K, adjusted EBITDA $667K
--------------------------------------------------------------------------------

- Net revenue $4.9M, up 38% from $3.5M in Q1 2024; core programmatic revenue grew 23%.
- Net income of $558,000 vs net loss of ($169,000) in Q1 2024; adjusted EBITDA $667,000 vs ($95,000).
- Gross margin improved to 65% from 62%; record active sites of 1,600.
- Cash and equivalents $4.1M, debt-free.
- Management notes Q1 included elevated emergency business not expected to persist; tariff uncertainties but strong positioning.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000164117225009262/0001641172-25-009262-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000164117225009262/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-009262

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer